All low-dose atropine Articles
-
257Research ReviewAtropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses
September 3, 2024 By Rumeysa Doger, BBioMed, OD Topical atropine is among the myopia treatments with proven efficacy, though treatment effect, side...
-
1.2KEditor’s PerspectiveCombination Therapy in Myopia Management
August 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE To determine the success of any juvenile-onset myopia intervention, it is...
-
89ClinicalWhich Myopic Children Will Benefit From Low-Dose Atropine?
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
-
694Latest Myopia NewsSydnexis Names Perry J. Sternberg CEO
July 16, 2024 DEL MAR, Calif. — Sydnexis has officially named a new Chief Executive Officer and member of the Board of...
-
104Practice ProfilesFrom High Myope to High Hopes: A New Chapter For Myopia Management
July 15, 2024 By Sami Khaldieh, OD I started researching myopia management in optometry school, where I was first introduced to it....
-
467Practice ProfilesThe Myopia Epidemic Prompted My Myopia Management Journey
June 17, 2024 By Marie Homa-Palladino, OD, FIAOMC, IACMM My journey in the eye care field began over 40 years ago, working...
-
804Research ReviewSignificant Advances in Myopia Control Strategies for Children
June 17, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE While myopia can be optically corrected, such corrections cannot address the...
-
590Clinical3 Reasons to Screen Your Orthokeratology Patients for Keratoconus
June 17, 2024 By Calista Ming, OD, FAAO, FSLS Since myopia has increasingly been recognized as a global public health issue, more...
-
748Research ReviewEfficacy of 0.01% Atropine Eye Drops for Myopia Control in European Children
June 3, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
780Patient Communication9 Steps to Guide Parents Through the Myopia Management Decision
June 3, 2024 By Sheila Morrison, OD, MSc, FSLS, FAAO By conducting thorough eye exams, educating parents on management options, engaging in...
-
394Latest Myopia NewsVyluma Receives EU Marketing Application Authorization for Low-Dose Atropine NVK002
May 29, 2024 BRIDGEWATER, N.J. — Vyluma announced it has received approval from the European Medicines Agency (EMA) of its Marketing Authorization...
-
582Practice ProfilesTalking About Your Passions Builds Myopia Management Success
May 15, 2024 By Arthur Jung, OD I have such a passion for myopia, and that’s clear in how I communicate with...
-
590PodcastsA Distant Mirror: How Is China Addressing Myopia?
May 6, 2024 While in Shanghai to attend the “Frontier in Vision Science Summit — Myopia Research,” Review of Myopia Management took...
-
923Latest Myopia NewsChina Hosts International Congress of Ophthalmology and Optometry
May 2, 2024 SHANGHAI, China – The International Congress of Ophthalmology and Optometry China (COOC) was held here April 11-13, 2024. With...
-
782Research ReviewSeeing Beyond Efficacy
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
-
1.5KInformed ConsentWhy Different FDA Indications Matter
April 15, 2024 Andrew Neukirch, OD The relationships my team and I cultivate with parents is built on trust. It’s my responsibility...
-
680Research ReviewFive-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study
April 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Topical low-concentration atropine eye drops to help slow the progression of...
-
627ImplementationHow to Bring Associate ODs on Board with Myopia Management
April 1, 2024 By Vishakha Thakrar, OD, FAAO, FSLS Implementing myopia management is no different than implementing other optometry specialties. We need...
-
284ClinicalLow-dose Atropine and OrthoK: What Does the Evidence Say?
April 1, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
212Practice ProfilesMy Personal Experience with Myopia Management Helps Me Provide Personalized Care
March 15, 2024 By Silvia Ruojin Ren, OD, MD, PhD Commitment to continuous learning is crucial given the dynamic nature of myopia...
-
865ClinicalLow-Dose Atropine: An Effective and Safe Option for Managing Juvenile-onset Myopia
sponsored content March 1, 2024 The evidence supporting the use of topical low-dose atropine in treating juvenile-onset myopia is so strong that...
-
699Research ReviewAssessing the Rebound Phenomenon in Different Myopia Control Treatments
March 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The prevalence of myopia has been increasing globally, and it is...
-
659Informed ConsentPrescribing Off-Label Myopia Management Treatments Gives Our Patients Their Best Chances of Success
February 15, 2024 By Glenda Aleman, OD Transparency can establish trust when talking to patients and parents about off-label treatments. I don’t...
-
1.2KImplementationAutonomy in My Practice Allowed Me to Practice Full Scope Myopia Management
February 15, 2024 By Nida Sherwani, OD I’ve been afforded the opportunity to dedicate myself wholeheartedly to myopia management. With newfound autonomy,...
-
1.1KResearch ReviewCompounded 0.01% Atropine — What’s in the Bottle?
February 1, 2024 By Luke Seesink, BApplSci According to this study, there is significant variability in the quality and consistency of compounded...
-
657Latest Myopia NewsEyenovia Regains Rights to MicroPine Atropine Spray in U.S. and Canada
January 18, 2024 NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by...
-
1.6KClinicalEarly Intervention of Low-Dose Atropine is Key for Juvenile-Onset Myopes
January 15, 2024 Review of Myopia Management interviewed Robert Clark, MD, to get the latest insights on treating myopes with low-dose atropine....